Apellis Pharmaceuticals, Inc. ($APLS)
Filing Information
| Accession Number | 0001492422-26-000030 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 15, 2026 |
| Document Date | Jan 13, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
1,780
Total Value
$39,493.22
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Business & Strat Officer | Common Stock | โ | Jan 13, 2026 | Sale | 1,780 | $22.19 | $39,493.22 | 83,058 | Direct | โ | View Details |